Inhibitory effect of baicalein combined with gemcitabine in human pancreatic cancer cell lines

Pancreatic cancer is an aggressive disease with a particularly poor prognosis contributing to a substantial percentage of cancer-associated mortality rates. In the present study, the combination treatment of baicalein (BAI) and gemcitabine (GEM) was investigated to examine whether it inhibited the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenlei, Zou, Xiaoping, Zhu, Hao, Chen, Min, Zhao, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840621/
https://www.ncbi.nlm.nih.gov/pubmed/29552186
http://dx.doi.org/10.3892/ol.2018.8043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840621/
https://www.ncbi.nlm.nih.gov/pubmed/29552186
http://dx.doi.org/10.3892/ol.2018.8043

Ejemplares similares